English

ALSERES PHARMACEUTICALS INC /DE

EDGAR

Quarterly report (10-Q) · filed 2014-08-14

86 filing records in this dataset, filed from 1996-05-30 to 2014-08-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

18.4 thousand USD

2014 Q2 · USD

Exact inputs and evidence

Revenue: 18432 USD Source

Operating margin

-1,720.5%

2014 Q2 · %

Exact inputs and evidence

Operating Income: -317123 USD Source
Revenue: 18432 USD Source

Operating cash flow

-272 thousand USD

2014 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -657514 USD Source
Operating Cash Flow: -385450 USD Source

Cash and cash equivalents: 46.4 thousand USD 2014-06-30 Source
Exact value

46444 USD
Long-term debt including current maturities: Not available
Shares outstanding: 30.6 million shares 2014-06-30 Source
Exact value

30635720 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

30635720 shares · 2013-06-30· Source
30635720 shares · 2014-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

474 thousand USD

2013-07-01 – 2014-06-30

Exact inputs and evidence

Revenue: 18432 USD · 2013-07-01 – 2013-09-30 Source
Revenue: 473730 USD · 2013-01-01 – 2013-12-31 Source
Revenue: 55296 USD · 2013-01-01 – 2013-09-30 Source
Revenue: 18432 USD · 2014-01-01 – 2014-03-31 Source
Revenue: 18432 USD · 2014-04-01 – 2014-06-30 Source

Net income

-777 thousand USD

2013-07-01 – 2014-06-30

Exact inputs and evidence

Net income: -362667 USD · 2013-07-01 – 2013-09-30 Source
Net income: -941529 USD · 2013-01-01 – 2013-12-31 Source
Net income: -1180574 USD · 2013-01-01 – 2013-09-30 Source
Net income: -332014 USD · 2014-01-01 – 2014-03-31 Source
Net income: -321001 USD · 2014-04-01 – 2014-06-30 Source

Operating cash flow

-1.34 million USD

2013-07-01 – 2014-06-30

Exact inputs and evidence

Operating cash flow: -1300953 USD · 2013-01-01 – 2013-09-30 Source
Operating cash flow: -1000163 USD · 2013-01-01 – 2013-06-30 Source
Operating cash flow: -1686929 USD · 2013-01-01 – 2013-12-31 Source
Operating cash flow: -1300953 USD · 2013-01-01 – 2013-09-30 Source
Operating cash flow: -385450 USD · 2014-01-01 – 2014-03-31 Source
Operating cash flow: -657514 USD · 2014-01-01 – 2014-06-30 Source
Operating cash flow: -385450 USD · 2014-01-01 – 2014-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2014-08-14.

Financial data available through: 2013-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2013-12-31
Operating income: 8 of 11 periods available· newest 2013-12-31
Net income: 10 of 11 periods available· newest 2013-12-31
Operating cash flow: 8 of 11 periods available· newest 2013-12-31
Capital expenditure: 1 of 11 periods available· newest 2011-12-31
Total assets: 7 of 11 periods available· newest 2013-12-31
Total liabilities: 6 of 11 periods available· newest 2013-12-31
Current assets: 7 of 11 periods available· newest 2013-12-31
Current liabilities: 7 of 11 periods available· newest 2013-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2013-12-31
long term debt: No compatible figures in this window
Shares outstanding: 3 of 11 periods available· newest 2013-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-10.7%

Prior period

USD 530,720

2012-01-01 – 2012-12-31
Current period

USD 473,730

2013-01-01 – 2013-12-31

Exact inputs and evidence

473730 − 530720 = -56990 USD

530720 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
473730 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ALSERES PHARMACEUTICALS INC /DE · 2013-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Year-over-year change in Revenue: -56990 USD Concept: fundies:Revenue Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 473730 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/000119312514137904/alse-20131231.xml#350249 Filing: 000119312514137904 Input fundies:Revenue: 530720 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/000119312514137904/alse-20131231.xml#414665 Filing: 000119312514137904
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 703,947

Prior period

−USD 1.65 million

2012-01-01 – 2012-12-31
Current period

−USD 941,529

2013-01-01 – 2013-12-31

Exact inputs and evidence

-941529 − -1645476 = 703947 USD

-1645476 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
-941529 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ALSERES PHARMACEUTICALS INC /DE · 2013-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Year-over-year change in Net income: 703947 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -941529 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/000119312514137904/alse-20131231.xml#352991 Filing: 000119312514137904 Input fundies:NetIncome: -1645476 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/000119312514137904/alse-20131231.xml#416836 Filing: 000119312514137904
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 734,480

Prior period

−USD 952,449

2012-01-01 – 2012-12-31
Current period

−USD 1.69 million

2013-01-01 – 2013-12-31

Exact inputs and evidence

-1686929 − -952449 = -734480 USD

-952449 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
-1686929 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ALSERES PHARMACEUTICALS INC /DE · 2013-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Year-over-year change in Operating cash flow: -734480 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1686929 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/000119312514137904/alse-20131231.xml#259643 Filing: 000119312514137904 Input fundies:OperatingCashFlow: -952449 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/000119312514137904/alse-20131231.xml#414086 Filing: 000119312514137904
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2013 2013-01-01 – 2013-12-31

Revenue USD 473,730 100% of revenue
Operating costs Derived USD 1.04 million 219% of revenue
Operating income −USD 564,723 −119% of revenue
Tax, interest and other Derived USD 376,806 80% of revenue
Net income −USD 941,529 −199% of revenue

Cash

Operating cash flow −USD 1.69 million −356% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2003 Not shown: operating income or net income is not reported.
2004 Not shown: operating income or net income is not reported.
2005 Not shown: operating income or net income is not reported.
2009 Not shown: operating income or net income is not reported.
2010 Not shown: operating income or net income is not reported.
2012 Operating loss: operating costs were 328% of revenue.
2013 Operating loss: operating costs were 219% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2003 2003-01-01 – 2003-12-31	0	7914887 Derived	-7914887	453107 Derived	-8367994	Unavailable	Source 2003-01-01 – 2003-12-31: 0 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -7914887 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -8367994 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -7814164 USD Inspect Operating Cash Flow Open source
2004 2004-01-01 – 2004-12-31	0	10381429 Derived	-10381429	869448 Derived	-11250877	Unavailable	Source 2004-01-01 – 2004-12-31: 0 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -10381429 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -11250877 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -9666437 USD Inspect Operating Cash Flow Open source
2005 2005-01-01 – 2005-12-31	0	11647984 Derived	-11647984	-146542 Derived	-11501442	Unavailable	Source 2005-01-01 – 2005-12-31: 0 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -11647984 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -11501442 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -10600774 USD Inspect Operating Cash Flow Open source
2009 2009-01-01 – 2009-12-31	0	8325982 Derived	-8325982	2450955 Derived	-10776937	Unavailable	Source 2009-01-01 – 2009-12-31: 0 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -8325982 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -10776937 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -8060298 USD Inspect Operating Cash Flow Open source
2010 2010-01-01 – 2010-12-31	0	3122937 Derived	-3122937	-3635356 Derived	512419	Unavailable	Source 2010-01-01 – 2010-12-31: 0 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -3122937 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: 512419 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -2950667 USD Inspect Operating Cash Flow Open source
2012 2012-01-01 – 2012-12-31	530720	1742891 Derived	-1212171	433305 Derived	-1645476	Unavailable	Source 2012-01-01 – 2012-12-31: 530720 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -1212171 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -1645476 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -952449 USD Inspect Operating Cash Flow Open source
2013 2013-01-01 – 2013-12-31	473730	1038453 Derived	-564723	376806 Derived	-941529	Unavailable	Source 2013-01-01 – 2013-12-31: 473730 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -564723 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -941529 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -1686929 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 473.7K 2013

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-12-31	Revenue	0	Revenue: 0 Open source
20042004-12-31	Revenue	0	Revenue: 0 Open source
20052005-12-31	Revenue	0	Revenue: 0 Open source
20092009-12-31	Revenue	0	Revenue: 0 Open source
20102010-12-31	Revenue	0	Revenue: 0 Open source
20122012-12-31	Revenue	530720	Revenue: 530720 Open source
20132013-12-31	Revenue	473730	Revenue: 473730 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-10.7% 2013

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20032003-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20042004-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20052005-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20092009-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20102010-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20122012-12-31	Year over year	No prior comparable period	Revenue: 530720 Open source
20132013-12-31	Year over year	-10.7%	Revenue: 473730 Open source Revenue: 530720 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -119.2% 2013

Net margin -198.7% 2013

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20032003-12-31	Operating margin	Not reported	Operating Income: -7914887 Open source Revenue: 0 Open source
20042004-12-31	Operating margin	Not reported	Operating Income: -10381429 Open source Revenue: 0 Open source
20052005-12-31	Operating margin	Not reported	Operating Income: -11647984 Open source Revenue: 0 Open source
20092009-12-31	Operating margin	Not reported	Operating Income: -8325982 Open source Revenue: 0 Open source
20102010-12-31	Operating margin	Not reported	Operating Income: -3122937 Open source Revenue: 0 Open source
20122012-12-31	Operating margin	-228.4%	Operating Income: -1212171 Open source Revenue: 530720 Open source
20132013-12-31	Operating margin	-119.2%	Operating Income: -564723 Open source Revenue: 473730 Open source
20032003-12-31	Net margin	Not reported	Net Income: -8367994 Open source Revenue: 0 Open source
20042004-12-31	Net margin	Not reported	Net Income: -11250877 Open source Revenue: 0 Open source
20052005-12-31	Net margin	Not reported	Net Income: -11501442 Open source Revenue: 0 Open source
20092009-12-31	Net margin	Not reported	Net Income: -10776937 Open source Revenue: 0 Open source
20102010-12-31	Net margin	Not reported	Net Income: 512419 Open source Revenue: 0 Open source
20122012-12-31	Net margin	-310%	Net Income: -1645476 Open source Revenue: 530720 Open source
20132013-12-31	Net margin	-198.7%	Net Income: -941529 Open source Revenue: 473730 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -7814164 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -9666437 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -10600774 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -8060298 Open source
20102010-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -2950667 Open source
20122012-12-31	Free cash flow margin	Not reported	Revenue: 530720 Open source Operating Cash Flow: -952449 Open source
20132013-12-31	Free cash flow margin	Not reported	Revenue: 473730 Open source Operating Cash Flow: -1686929 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.7M 2013

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-12-31	Operating cash flow	-7814164	Operating Cash Flow: -7814164 Open source
20042004-12-31	Operating cash flow	-9666437	Operating Cash Flow: -9666437 Open source
20052005-12-31	Operating cash flow	-10600774	Operating Cash Flow: -10600774 Open source
20092009-12-31	Operating cash flow	-8060298	Operating Cash Flow: -8060298 Open source
20102010-12-31	Operating cash flow	-2950667	Operating Cash Flow: -2950667 Open source
20122012-12-31	Operating cash flow	-952449	Operating Cash Flow: -952449 Open source
20132013-12-31	Operating cash flow	-1686929	Operating Cash Flow: -1686929 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-12-31	Free cash flow	Unavailable	Operating Cash Flow: -7814164 Open source
20042004-12-31	Free cash flow	Unavailable	Operating Cash Flow: -9666437 Open source
20052005-12-31	Free cash flow	Unavailable	Operating Cash Flow: -10600774 Open source
20092009-12-31	Free cash flow	Unavailable	Operating Cash Flow: -8060298 Open source
20102010-12-31	Free cash flow	Unavailable	Operating Cash Flow: -2950667 Open source
20122012-12-31	Free cash flow	Unavailable	Operating Cash Flow: -952449 Open source
20132013-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1686929 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

2,764.1% 2013

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2003-12-31	Liabilities / assets	Not reported	Total Assets: 17432894 Open source
20042004-12-31	Liabilities / assets	77.6%	Total Liabilities: 1975773 Open source Total Assets: 2544713 Open source
20052005-12-31	Liabilities / assets	25%	Total Liabilities: 2624182 Open source Total Assets: 10515488 Open source
20092009-12-31	Liabilities / assets	5,466.9%	Total Liabilities: 43233218 Open source Total Assets: 790815 Open source
20102010-12-31	Liabilities / assets	9,187.9%	Total Liabilities: 42318715 Open source Total Assets: 460592 Open source
20122012-12-31	Liabilities / assets	2,828.7%	Total Liabilities: 27317077 Open source Total Assets: 965707 Open source
20132013-12-31	Liabilities / assets	2,764.1%	Total Liabilities: 10654846 Open source Total Assets: 385471 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.2× 2013

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20032003-12-31	Current assets / current liabilities	3.13×	Current Assets: 11926733 Open source Current Liabilities: 3811129 Open source
20042004-12-31	Current assets / current liabilities	0.91×	Current Assets: 1788243 Open source Current Liabilities: 1975773 Open source
20052005-12-31	Current assets / current liabilities	4.18×	Current Assets: 9815936 Open source Current Liabilities: 2349856 Open source
20092009-12-31	Current assets / current liabilities	0.01×	Current Assets: 388123 Open source Current Liabilities: 43136792 Open source
20102010-12-31	Current assets / current liabilities	0×	Current Assets: 208750 Open source Current Liabilities: 42288212 Open source
20122012-12-31	Current assets / current liabilities	0.09×	Current Assets: 900007 Open source Current Liabilities: 10066780 Open source
20132013-12-31	Current assets / current liabilities	0.2×	Current Assets: 324644 Open source Current Liabilities: 1648320 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2003 2003-01-01 – 2003-12-31	−USD 8.37 million Exact value Exact value: -8367994 USD 2003-01-01 – 2003-12-31: -8367994 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALSERES PHARMACEUTICALS INC /DE · 2003-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Net Income: -8367994 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8367994 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/0000950135-06-002018.txt#14188 The citation records this snapshot. The page link may show a newer release later.	−USD 7.81 million Exact value Exact value: -7814164 USD 2003-01-01 – 2003-12-31: -7814164 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALSERES PHARMACEUTICALS INC /DE · 2003-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Operating Cash Flow: -7814164 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7814164 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/0000950135-06-002018.txt#14507 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2004 2004-01-01 – 2004-12-31	−USD 11.25 million Exact value Exact value: -11250877 USD 2004-01-01 – 2004-12-31: -11250877 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALSERES PHARMACEUTICALS INC /DE · 2004-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Net Income: -11250877 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11250877 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/0000950135-06-002018.txt#14188 The citation records this snapshot. The page link may show a newer release later.	−USD 9.67 million Exact value Exact value: -9666437 USD 2004-01-01 – 2004-12-31: -9666437 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALSERES PHARMACEUTICALS INC /DE · 2004-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Operating Cash Flow: -9666437 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9666437 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/0000950135-06-002018.txt#14507 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2005 2005-01-01 – 2005-12-31	−USD 11.5 million Exact value Exact value: -11501442 USD 2005-01-01 – 2005-12-31: -11501442 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALSERES PHARMACEUTICALS INC /DE · 2005-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Net Income: -11501442 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11501442 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/0000950135-06-002018.txt#14188 The citation records this snapshot. The page link may show a newer release later.	−USD 10.6 million Exact value Exact value: -10600774 USD 2005-01-01 – 2005-12-31: -10600774 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALSERES PHARMACEUTICALS INC /DE · 2005-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Operating Cash Flow: -10600774 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10600774 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/0000950135-06-002018.txt#14507 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2007 2007-01-01 – 2007-12-31	−USD 19.55 million Exact value Exact value: -19548348 USD 2007-01-01 – 2007-12-31: -19548348 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALSERES PHARMACEUTICALS INC /DE · 2007-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Net Income: -19548348 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19548348 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/000119312514137904/alse-20131231.xml#73762 Filing: 000119312514137904 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2008 2008-01-01 – 2008-12-31	−USD 20.85 million Exact value Exact value: -20847459 USD 2008-01-01 – 2008-12-31: -20847459 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALSERES PHARMACEUTICALS INC /DE · 2008-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Net Income: -20847459 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20847459 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/000119312514137904/alse-20131231.xml#406824 Filing: 000119312514137904 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2009 2009-01-01 – 2009-12-31	−USD 10.78 million Exact value Exact value: -10776937 USD 2009-01-01 – 2009-12-31: -10776937 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALSERES PHARMACEUTICALS INC /DE · 2009-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Net Income: -10776937 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10776937 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/000119312514137904/alse-20131231.xml#79475 Filing: 000119312514137904 The citation records this snapshot. The page link may show a newer release later.	−USD 8.06 million Exact value Exact value: -8060298 USD 2009-01-01 – 2009-12-31: -8060298 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALSERES PHARMACEUTICALS INC /DE · 2009-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Operating Cash Flow: -8060298 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8060298 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/0000950123-11-031417.txt#9612 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	USD 512,419 Exact value Exact value: 512419 USD 2010-01-01 – 2010-12-31: 512419 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALSERES PHARMACEUTICALS INC /DE · 2010-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Net Income: 512419 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: 512419 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/000119312514137904/alse-20131231.xml#82739 Filing: 000119312514137904 The citation records this snapshot. The page link may show a newer release later.	−USD 2.95 million Exact value Exact value: -2950667 USD 2010-01-01 – 2010-12-31: -2950667 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALSERES PHARMACEUTICALS INC /DE · 2010-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Operating Cash Flow: -2950667 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2950667 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/000119312512139930/alse-20111231.xml#64257 Filing: 000119312512139930 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2011 2011-01-01 – 2011-12-31	−USD 2.88 million Exact value Exact value: -2882214 USD 2011-01-01 – 2011-12-31: -2882214 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALSERES PHARMACEUTICALS INC /DE · 2011-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Net Income: -2882214 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2882214 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/000119312514137904/alse-20131231.xml#86766 Filing: 000119312514137904 The citation records this snapshot. The page link may show a newer release later.	−USD 2.48 million Exact value Exact value: -2484803 USD 2011-01-01 – 2011-12-31: -2484803 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALSERES PHARMACEUTICALS INC /DE · 2011-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Operating Cash Flow: -2484803 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2484803 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/000119312513136073/alse-20121231.xml#563717 Filing: 000119312513136073 The citation records this snapshot. The page link may show a newer release later.	USD 2,373 Exact value Exact value: 2373 USD 2011-01-01 – 2011-12-31: 2373 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALSERES PHARMACEUTICALS INC /DE · 2011-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Capital Expenditure: 2373 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2373 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/000119312513136073/alse-20121231.xml#577067 Filing: 000119312513136073 The citation records this snapshot. The page link may show a newer release later.	−USD 2.49 million Calculation and evidence -2484803 − 2373 USD Exact free cash flow: -2487176 USD 2011-01-01 – 2011-12-31: -2484803 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 2373 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALSERES PHARMACEUTICALS INC /DE · 2011-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Free cash flow: -2487176 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2484803 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/000119312513136073/alse-20121231.xml#563717 Filing: 000119312513136073 Input fundies:CapitalExpenditure: 2373 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/000119312513136073/alse-20121231.xml#577067 Filing: 000119312513136073 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 1.65 million Exact value Exact value: -1645476 USD 2012-01-01 – 2012-12-31: -1645476 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALSERES PHARMACEUTICALS INC /DE · 2012-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Net Income: -1645476 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1645476 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/000119312514137904/alse-20131231.xml#416836 Filing: 000119312514137904 The citation records this snapshot. The page link may show a newer release later.	−USD 952,449 Exact value Exact value: -952449 USD 2012-01-01 – 2012-12-31: -952449 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALSERES PHARMACEUTICALS INC /DE · 2012-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Operating Cash Flow: -952449 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -952449 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/000119312514137904/alse-20131231.xml#414086 Filing: 000119312514137904 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2013 2013-01-01 – 2013-12-31	−USD 941,529 Exact value Exact value: -941529 USD 2013-01-01 – 2013-12-31: -941529 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALSERES PHARMACEUTICALS INC /DE · 2013-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Net Income: -941529 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -941529 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/000119312514137904/alse-20131231.xml#352991 Filing: 000119312514137904 The citation records this snapshot. The page link may show a newer release later.	−USD 1.69 million Exact value Exact value: -1686929 USD 2013-01-01 – 2013-12-31: -1686929 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALSERES PHARMACEUTICALS INC /DE · 2013-12-31 ALSERES PHARMACEUTICALS INC /DE (edgar:94784) Operating Cash Flow: -1686929 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:03:51Z Snapshot: 067860da1d31c77b1fe0c8e8fbbc27c7aa7d179b60a0a6c305abb94aa491176d Dimensions: Consolidated View: https://fundies.io/companies/edgar/94784/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1686929 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/94784/000119312514137904/alse-20131231.xml#259643 Filing: 000119312514137904 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

86 filings · 975 latest values · 975 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000094784, 94784, edgar:94784

Also known as ALSERES PHARMACEUTICALS INC /DE, BOSTON LIFE SCIENCES INC /DE

ALSERES PHARMACEUTICALS INC /DE

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2013 2013-01-01 – 2013-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation